Actelion Pharmaceuticals Ltd registered domain names
See 10 domain name(s) that specified Actelion Pharmaceuticals Ltd as their possible contact address.
Number of websites/domains displayed: 10
Results found: 10
Websites discovered:
Stage IA & IB mycosis fungoides–type cutaneous t-cell lymphoma | VALCHLOR (mechlorethamine)http://pageoverview.com/website-report/valchlor.com
Information for patients about an FDA-approved topical prescription medicine for Stage IA & IB mycosis fungoides–type cutaneous t-cell lymphoma. Find important safety information medication guide and prescribing information.
- Expected expiration: October 25th in 2017
- Creation date: October 25th in 2011
- Renew date: October 21st in 2016
- Google Analytics: 55588032-1
Actelion Pharmaceuticals US, Inchttp://pageoverview.com/website-report/actelion.us
Actelion Pharmaceuticals Ltd is a biopharmaceutical company, that focuses on the discovery, development and commercialization of innovative treatments to serve high unmet medical needs.
- Expected expiration: May 6th in 2017
- Creation date: May 6th in 2002
- Renew date: March 2nd in 2012
Actelion Pharmaceuticals Italiahttp://pageoverview.com/website-report/actelion.it
- Expected expiration: January 23rd in 2019
- Creation date: October 8th in 2002
- Renew date: February 8th in 2018
Actelion Pharmaceuticals Ltd - Shaping our Futurehttp://pageoverview.com/website-report/actelion.com
Actelion Pharmaceuticals Ltd is a biopharmaceutical company, that focuses on the discovery, development and commercialization of innovative treatments to serve high unmet medical needs.
- Expected expiration: January 14th in 2018
- Creation date: January 15th in 1998
- Renew date: January 10th in 2017
Actelion Pharmaceuticals UK Ltdhttp://pageoverview.com/website-report/actelion.co.uk
Actelion Pharmaceuticals UK Ltd is the UK affiliate of Actelion Pharmaceuticals Ltd, a biopharmaceutical company. Actelion focuses on the discovery, development and commercialization of innovative treatments to serve high unmet medical needs.
- Renew date: February 18th in 2018
Actelion Pharmaceuticals France SAShttp://pageoverview.com/website-report/actelion.fr
Actelion est une société biopharmaceutique, dont le siège social se trouve près de Bâle
- Expected expiration: March 5th in 2018
- Creation date: October 3rd in 2002
- Renew date: March 1st in 2017
Doença de Gaucherhttp://pageoverview.com/website-report/doencadegaucher.com.br
- Expected expiration: March 6th in 2018
- Creation date: March 6th in 2007
- Renew date: February 6th in 2017
- Google Analytics: 55901203-1
PAH Treatment OPSUMIT® (macitentan)http://pageoverview.com/website-report/opsumit.com
Learn about pulmonary arterial hypertension treatment with OPSUMIT® (PAH, WHO Group 1).
- Expected expiration: January 7th in 2018
- Creation date: January 7th in 2011
- Renew date: January 3rd in 2017
- Google Analytics: 50780211-1
Főoldalhttp://pageoverview.com/website-report/actelion.hu
Az Actelion Pharmaceuticals Ltd biogyógyszer-ipari vállalat, mely a kielégítetlen orvosi igények megoldását szolgáló új kezelések felfedezésére, fejlesztésére és forgalmazására összpontosít.
- Creation date: January 3rd in 2014